Honkarakenne Oyj
CONSTITUENT MEETING OF HONKARAKENNE’S BOARD OF DIRECTORS AND COMMITTEES
CONSTITUENT MEETING OF HONKARAKENNE’S BOARD OF DIRECTORS AND COMMITTEES
HONKARAKENNE OYJ Stock Exchange Release 11 April 2025 at 17:00
CONSTITUENT MEETING OF HONKARAKENNE’S BOARD OF DIRECTORS AND COMMITTEES
Honkarakenne Oyj’s Annual General Meeting held on Friday 11 April 2025 in Honkarakenne’s Tuusula office at Lahdentie 870, Tuusula, Finland. The Annual General Meeting elected the following persons to the Board of Directors: Arto Halonen, Timo Kohtamäki, Maria Ristola and Rose-Mari Saarelainen.
The Board of Directors convened for its constituent meeting and appointed Timo Kohtamäki as Chairman of the Board and Maria Ristola as Vice Chairman of the Board.
At the same board meeting Board of Directors decided not to set up any committees.
HONKARAKENNE OYJ
Marko Saarelainen
President and CEO
Further information:
Marko Saarelainen, President and CEO, tel. +358 40 542 0254, marko.saarelainen@honka.com or
Maarit Jylhä, CFO, tel. +358 40 594 4099, maarit.jylha@honka.com
DISTRIBUTION
Nasdaq Helsinki Ltd
Financial Supervisory Authority
www.honka.com
Honkarakenne Oyj manufactures high-quality, healthy and ecological log homes, holiday homes and public buildings under its Honka® brand from Finnish solid wood. The company has delivered 90,000 buildings to over 50 countries. House kits are manufactured in Finland, the company's own factory is located in Karstula. In 2024, Honkarakenne Group's net sales were EUR 36.7 million, of which exports accounted for 29%. www.honka.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
EVS Broadcast Equipment18.4.2025 18:30:00 CEST | Press release
EVS Broadcast Equipment reports update of share buyback program
AMG Critical Materials N.V.18.4.2025 18:00:00 CEST | Press release
AMG Signs Exclusive Agreement with Grupo Lagoa
Syensqo SA18.4.2025 17:45:00 CEST | Press release
Syensqo - Acquisition of own shares
Ageas18.4.2025 17:40:00 CEST | Press release
Ageas announces the Ordinary and Extraordinary General Meetings of Shareholders of ageas SA/NV
Sanofi Winthrop Industrie18.4.2025 17:15:00 CEST | Press release
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom